JHS Svendgaard Laboratories マネジメント

マネジメント基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Paramvir Pabla

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	10.5yrs
CEOの所有権	n/a
経営陣の平均在職期間	3.4yrs
取締役会の平均在任期間	4.4yrs

経営陣の近況

Recent updates

CEO報酬分析

JHS Svendgaard Laboratories の収益と比較して、Paramvir Pabla の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2024	n/a	n/a	-₹231m
Jun 30 2024	n/a	n/a	-₹21m
Mar 31 2024	n/a	n/a	-₹155m
Dec 31 2023	n/a	n/a	-₹111m
Sep 30 2023	n/a	n/a	-₹139m
Jun 30 2023	n/a	n/a	-₹144m
Mar 31 2023	n/a	n/a	-₹41m
Dec 31 2022	n/a	n/a	-₹99m
Sep 30 2022	n/a	n/a	-₹82m
Jun 30 2022	n/a	n/a	-₹77m
Mar 31 2022	n/a	n/a	-₹41m
Dec 31 2021	n/a	n/a	₹29m
Sep 30 2021	n/a	n/a	₹28m
Jun 30 2021	n/a	n/a	₹35m
Mar 31 2021	₹3m	n/a	₹12m
Dec 31 2020	n/a	n/a	-₹32m
Sep 30 2020	n/a	n/a	-₹27m
Jun 30 2020	n/a	n/a	-₹42m
Mar 31 2020	₹3m	₹3m	-₹20m
Dec 31 2019	n/a	n/a	-₹3m
Sep 30 2019	n/a	n/a	-₹15m
Jun 30 2019	n/a	n/a	-₹5m
Mar 31 2019	₹3m	₹3m	-₹7m
Dec 31 2018	n/a	n/a	₹23m
Sep 30 2018	n/a	n/a	₹40m
Jun 30 2018	n/a	n/a	₹67m
Mar 31 2018	₹2m	₹2m	₹261m

報酬と市場: Paramvirの総報酬がIndian市場の同規模の企業と比較して妥当かどうかを判断するにはデータが不十分です。

報酬と収益: Paramvirの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Paramvir Pabla (46 yo)

10.5yrs

在職期間

₹3,037,000

報酬

Mr. Paramvir Singh Pabla serves as Chief Executive Officer of JHS Svendgaard Laboratories Limited since May 30, 2014. He joined JHS Svendgaard Laboratories Limited on June 30, 2010.

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Nikhil Nanda	MD & Executive Director	19.6yrs	₹6.96m	30.95% ₹ 575.3m
Paramvir Pabla	Chief Executive Officer	10.5yrs	₹3.04m	データなし
Ashish Goel	Chief Financial Officer	1.1yrs	₹2.43m	データなし
Rakesh Sabharwal	General Manager of Accounts	no data	データなし	データなし
Komal Jha	Company Secretary & Compliance Officer	2yrs	データなし	データなし
Kashyap Borua	Head of Marketing	3.4yrs	データなし	データなし

3.4yrs

平均在職期間

46yo

平均年齢

経験豊富な経営陣: 532771の経営陣は経験豊富であると考えられます ( 3.4年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Nikhil Nanda	MD & Executive Director	20.1yrs	₹6.96m	30.95% ₹ 575.3m
Mukul Pathak	Independent Non Executive Director	9.3yrs	₹70.00k	データなし
Rajagopal Venkateish	Independent Chairman	4.4yrs	₹150.00k	データなし
Upma Chawdhry	Independent Director	1.3yrs	₹20.00k	データなし
Vinay Mittal	Additional Non-Executive Non-Independent Director	2.5yrs	データなし	データなし
Kapil Minocha	Non-Executive Independent Director	4.4yrs	₹90.00k	データなし

4.4yrs

平均在職期間

65yo

平均年齢

経験豊富なボード: 532771の取締役会は経験豊富であると考えられます ( 4.4年の平均在任期間)。

JHS Svendgaard Laboratories マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

JHS Svendgaard Laboratories Limited, Annual General Meeting, Sep 10, 2024

JHS Svendgaard Laboratories Limited Announces the Resignation of Mr. Deepesh Sharma as Joint Chief Financial Officer

JHS Svendgaard Laboratories Limited Announces Cessation of Rohina Sanjay Sangtani as Independent Director

JHS Svendgaard Laboratories Limited, Annual General Meeting, Sep 28, 2023

JHS Svendgaard Laboratories Limited, Annual General Meeting, Sep 28, 2023

JHS Svendgaard Laboratories Limited Appoints Deepesh Sharma as Joint Chief Financial Officer

Recent updates

Second quarter 2025 earnings released: ₹1.24 loss per share (vs ₹0.09 loss in 2Q 2024)

JHS Svendgaard Laboratories Limited to Report Q2, 2025 Results on Nov 13, 2024

JHS Svendgaard Laboratories Limited, Annual General Meeting, Sep 10, 2024

First quarter 2025 earnings released: ₹0.08 loss per share (vs ₹0.40 loss in 1Q 2024)

JHS Svendgaard Laboratories Limited to Report Q1, 2025 Results on Aug 12, 2024

JHS Svendgaard Laboratories Limited to Report Q1, 2025 Results on Aug 12, 2024

JHS Svendgaard Laboratories Limited announced that it expects to receive INR 300 million in funding from COEUS Global Opportunities Fund, M.B. Finmart Private Limited, Milky Investment And Trading Company, Puran Associates Pvt. Ltd., Vic Enterprises Private Limited and another investor

JHS Svendgaard Laboratories Limited to Report Q4, 2024 Results on May 18, 2024

Third quarter 2024 earnings released: EPS: ₹0.002 (vs ₹0.24 loss in 3Q 2023)

JHS Svendgaard Laboratories Limited to Report Nine Months, 2024 Results on Feb 14, 2024

New major risk - Share price stability

New minor risk - Share price stability

Second quarter 2024 earnings released: ₹0.09 loss per share (vs ₹0.03 loss in 2Q 2023)

JHS Svendgaard Laboratories Limited to Report First Half, 2024 Results on Nov 07, 2023

JHS Svendgaard Laboratories Limited Announces the Resignation of Mr. Deepesh Sharma as Joint Chief Financial Officer

JHS Svendgaard Laboratories Limited Announces Cessation of Rohina Sanjay Sangtani as Independent Director

New minor risk - Shareholder dilution

JHS Svendgaard Laboratories Limited, Annual General Meeting, Sep 28, 2023

JHS Svendgaard Laboratories Limited, Annual General Meeting, Sep 28, 2023

JHS Svendgaard Laboratories Limited (NSEI:JHS) agreed to acquire Vedic Cosmeceuticals Pvt. Ltd.

First quarter 2024 earnings released: ₹0.40 loss per share (vs ₹0.59 loss in 1Q 2023)

JHS Svendgaard Laboratories Limited to Report Q1, 2024 Results on Aug 14, 2023

New minor risk - Share price stability

Full year 2023 earnings released: ₹2.34 loss per share (vs ₹0.63 loss in FY 2022)

JHS Svendgaard Laboratories Limited Appoints Deepesh Sharma as Joint Chief Financial Officer

JHS Svendgaard Laboratories Limited to Report Q4, 2023 Results on May 30, 2023

Now 20% undervalued after recent price drop

Third quarter 2023 earnings released: ₹0.24 loss per share (vs ₹0.04 profit in 3Q 2022)

JHS Svendgaard Laboratories Limited Announces the Resignation of Neeraj Kumar as Joint Chief Financial Officer, Effective March 15, 2023

JHS Svendgaard Laboratories Limited to Report Q3, 2023 Results on Feb 14, 2023

Second quarter 2023 earnings released: ₹0.03 loss per share (vs ₹0.05 profit in 2Q 2022)

Second quarter 2023 earnings released: ₹0.03 loss per share (vs ₹0.05 profit in 2Q 2022)

JHS Svendgaard Laboratories Limited Appoints Komal Jha as Company Secretary & Compliance Officer

JHS Svendgaard Laboratories Limited to Report Q2, 2023 Results on Nov 10, 2022

JHS Svendgaard Laboratories Limited, Annual General Meeting, Sep 27, 2022

First quarter 2023 earnings released

JHS Svendgaard Laboratories Limited to Report Q1, 2023 Results on Aug 09, 2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

JHS Svendgaard Laboratories Limited Announces Management Changes

JHS Svendgaard Laboratories Limited to Report Q4, 2022 Results on May 24, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

JHS Svendgaard Laboratories Limited Announces Resignation of Mr. Nokhil Kishorchandra Vora as Nominee Director

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

JHS Svendgaard Laboratories Limited to Report Q3, 2022 Results on Feb 08, 2022

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS ₹0.05 (vs ₹0.16 in 2Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹0.20 (vs ₹0.33 loss in FY 2020)

JHS Svendgaard Laboratories Limited Update on Its Operations

Third quarter 2021 earnings released: EPS ₹0.02 (vs ₹0.11 in 3Q 2020)

JHS Svendgaard Laboratories Limited to Report Q3, 2021 Results on Feb 09, 2021

New 90-day high: ₹26.80

New 90-day high: ₹26.45

JHS Svendgaard Laboratories Limited to Report Q2, 2021 Results on Nov 03, 2020

First quarter earnings released

JHS Svendgaard Laboratories Limited Announces Resignation of Balbir Verma, Non-Executive Independent Director

JHS Svendgaard Laboratories Limited to Report Q1, 2021 Results on Sep 15, 2020

New 90-day high - ₹19.50

JHS Svendgaard Laboratories Limited announced that it expects to receive INR 27.5 million in funding

CEO報酬分析

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

マネジメント基準チェック /24